Gary L. Herman - 05 Jul 2024 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VRPX	Stock Option (right to buy)	Award	$0	+2,500		$0.000000	2,500	05 Jul 2024	Common Stock	2,500	$0.5780	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests in full on the twelve-month anniversary of the grant date.